Skip to content

MODUS VIVENDI

Active
Private limited companyfounded 2005active for 20 yearsRue Hector Delaissé(RS) 17, 7610 Rumes, BelgiumKBO/BCE: BE 0876.861.291
Summary

MODUS VIVENDI has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €433,499 and a net result of €64,847. Equity is growing by about 7.1% per year across the filed financial years. Its solvency ranks better than 55% of 634 sector peers (NACE 72, financial year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Research and development on biotechnology
NACE 72101General medical practice NACE 86210
1 site
Size
€639,441total assets 2024
Equity
€433,499
Profit
€64,847
Turnover not published (micro format)
Financial health
88 Excellent Checked score 2024
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Accounts 70 days overdue0 of 2 deeds read
Why 88raises risk1 financial year not filed after the legal deadline; latest accounts 61 days late; 3 of the last 3 lateFigures for financial year 2024 (filed 08-10-2025)lowers riskLiquidity: current ratio 5.79, cash €147,834Founded in 2005Show the evidence

Checked score

Score 2024
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 61% of its sector peers (NACE 72, micro)
Financial strength · tick = 2022
Strong
Solvency 93+7
equity 67.8% of total assets
Liquidity 79-3
short-term debt 7.1% · cash 23.1%
Profitability 81=
return on assets 10.1%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (936 companies, NACE 72, micro)
Last 24 months 11-2024: 0.4% 12-2024: 0.6%▲ +0.2 percentage points vs 11-2024 01-2025: 1.5%▲ +0.9 percentage points vs 12-2024 02-2025: 1.5%● unchanged vs 01-2025 03-2025: 1.6%▲ +0.1 percentage points vs 02-2025 04-2025: 1.5%▼ -0.1 percentage points vs 03-2025 05-2025: 1.5%● unchanged vs 04-2025 06-2025: 1.5%● unchanged vs 05-2025 07-2025: 1.5%● unchanged vs 06-2025 08-2025: 2.4%▲ +0.9 percentage points vs 07-2025highest value 09-2025: 2.4%● unchanged vs 08-2025 10-2025: 2.4%● unchanged vs 09-2025 11-2025: 0.1%▼ -2.3 percentage points vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.3%▲ +0.1 percentage points vs 09-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity ample (current ratio 5.79, compared with 4.3 in 2022; short-term debt: 7.1% and cash: 23.1% of total assets), and 32.2% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 60% on solvency, 65% on liquidity and 58% on profitability.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Liquidity: current ratio 5.79, cash €147,834
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; latest accounts 61 days late; 3 of the last 3 late
NBB · filings
lowers risk · Founded in 2005
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Figures for financial year 2024 (filed 08-10-2025)
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of Belgian companies file late, and of those that file 1 to 90 days late, 2.0% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
61 days late
2022
138 days late
2021
141 days late
2020
31 days late
2019
31 days late
2018
30 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 72 days after the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · micro…
  2. Annual accounts filedfinancial year 2022 · micro…
  3. Highest result from 2018 to 2024net €65,576 ▲184%

Key points

  • Caution: Accounts not fileddeadline was 31-07-2026 70 days late View
  • Positive: 6 profitable years in a rowprofit 2024: €64,847 6 years View
  • Total assets 20246 financial years filed €639,441 View

By topic

Financials

Financial year
2024
Total assets
€639,441
Profit
€64,847
Solvency
67.8%
Total assets▼ 5.4%
Net result
20182024
Go to Financials

Timeline

Events
20
Since
2007
  1. 19-12-2022Annual accounts filed
  2. 31-08-2021Annual accounts filed
  3. 31-08-2020Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
24-10-2005
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.